System Biosciences (SBI), a leading provider of exosome research tools and services, announced today that QIAGEN, a leading global provider of Sample to Insights solutions for molecular diagnostics and life sciences, has signed a non-exclusive, worldwide license for SBI’s patented ExoQuick® technology for research use. PALO ALTO, Calif. System Biosciences (SBI), a leading provider of […]
La Vista, NE – Streck, Inc. and Van Xuan Medical Technology, a pharmaceutical distributor in Ho Chi Minh City, Vietnam, have signed a three-year distribution agreement for Streck’s full portfolio of controls, cell stabilization and molecular products. Streck’s cell stabilization products include Cyto-Chex® BCT, a blood collection tube for the preservation of whole blood specimens […]
March 27, 2018 Biopharmaceuticals represent the fastest growing sector of the pharmaceutical industry, mainly driven by a rapid expansion in the manufacture of recombinant protein-based drugs [1]. The majority of the therapeutic proteins are glycoproteins (monoclonal antibodies, blood proteins, growth factors, vaccines, fusion proteins) and hence, glycosylation is the most prominent post-translational modifications occurring on […]
SAN DIEGO — Organovo Holdings, Inc. (NASDAQ:ONVO) (“Organovo”) today announced that its wholly-owned subsidiary, Samsara Sciences, Inc. (“Samsara”), a provider of highly specialized human liver cells, entered a non-exclusive global supply agreement with Lonza Bioscience Solutions (“Lonza”). Under the terms of the agreement, Lonza will market human cell products from Samsara for further distribution to its customers. “We’re incredibly pleased to […]
Explore molecular interaction at the speed of life with the SP8 FALCON from Leica Microsystems Mannheim, Germany. Leica Microsystems announces the SP8 FALCON, the world’s first truly integrated lifetime contrast microscope. The SP8 FALCON can record lifetime contrast 10x faster than previous solutions. This lifetime information lets researchers monitor interactions between proteins in living cells […]
AMSBIO has signed an agreement with Genea Biocells (San Diego, USA) to become global distribution partner to the academic community for its groundbreaking skeletal muscle differentiation product range. Genea Biocells developed the world’s first protocol to robustly differentiate human pluripotent stem cells to skeletal muscle cells with high yields and without cell sorting or genetic manipulation (Caron et al. […]
New and updated assays increase application areas and improve performance MINNEAPOLIS — Bio-Techne has expanded the automation capabilities of its popular Advanced Cell Diagnostics (ACD)-branded RNAscope® in situ hybridization (ISH) technology with the launch of several new and updated assays. The developments increase both access to, and use of, RNAscope and improve overall robustness and ease-of-use. The continued investment in […]
Location: Cambridge Horizon’s Glutamine Synthetase-Knockout CHO K1 cell line has been used as part of a successful Investigational New Drug filing with the FDA Filing further validates the use of Horizon’s Bioproduction cell line platform for the manufacture of biotherapeutics Cambridge, UK: Horizon Discovery Group plc (LSE: HZD) (“Horizon” or “the Group”), a global leader […]
FARMINGDALE, N.Y. – EpiGentek, a NY-based biotechnology firm specializing in epigenetic research products and services, announced its technological and financial support for new skincare startup EpigenCare. William Lee, who served as an operations executive for a number of years at EpiGentek, spearheads EpigenCare’s venture as its CEO. EpiGentek will work in collaboration with EpigenCare to […]
Lawrence, MA — Nexcelom Bioscience, a leading provider of cell counting and analysis products for biomedical research and the biopharma industry, announced today that it has received a strategic investment from Ampersand Capital Partners. The funding will be primarily used to support Nexcelom’s worldwide growth initiatives. Founded in 2003, Nexcelom is a fast-growing supplier of innovative […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
